BioPharma Credit PLC Notice of Half Year Results (8498K)
31 Agosto 2023 - 3:00AM
UK Regulatory
TIDMBPCR
RNS Number : 8498K
BioPharma Credit PLC
31 August 2023
31 August 2023
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF HALF YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its Half Year Results for the period
ending 30 June 2023 on Wednesday 27 September 2023.
A management presentation will be delivered at 14.00 BST through
a webcast facility. To register to attend or request details, RSVP
to biopharmacredit@buchanan.uk.com .
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0)333 300 1950
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORKZGFRDGLGFZM
(END) Dow Jones Newswires
August 31, 2023 02:00 ET (06:00 GMT)
Biopharma Credit (LSE:BPCP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Biopharma Credit (LSE:BPCP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024